Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial

Abstract Background Although evidence is accumulating that lifestyle modification may be cost-effective in patients with prediabetes, information is limited on the cost-effectiveness of interventions implemented in public health and primary health care settings. Evidence from well-conducted pragmatic trials is needed to gain insight into the realistic cost-effectiveness of diabetes prevention interventions in real-world settings. The aim of this study is to assess the cost-effectiveness of the SLIMMER lifestyle intervention targeted at patients at high risk of developing type 2 diabetes compar... Mehr ...

Verfasser: Geerke Duijzer
Andrea J. Bukman
Aafke Meints-Groenveld
Annemien Haveman-Nies
Sophia C. Jansen
Judith Heinrich
Gerrit J. Hiddink
Edith J. M. Feskens
G. Ardine de Wit
Dokumenttyp: Artikel
Erscheinungsdatum: 2019
Reihe/Periodikum: BMC Health Services Research, Vol 19, Iss 1, Pp 1-10 (2019)
Verlag/Hrsg.: BMC
Schlagwörter: Cost-effectiveness / Diabetes / Prevention / Lifestyle intervention / Economic evaluation / Public aspects of medicine / RA1-1270
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26630158
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1186/s12913-019-4529-8